sincalide and Parkinson-Disease

sincalide has been researched along with Parkinson-Disease* in 3 studies

Reviews

1 review(s) available for sincalide and Parkinson-Disease

Article	Year
New perspectives in the treatment of Parkinson's disease. Clinical neuropharmacology, 1986, Volume: 9 Suppl 1 Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Selegiline; Sincalide	1986

Trials

1 trial(s) available for sincalide and Parkinson-Disease

Article	Year
Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease. Annals of the New York Academy of Sciences, 1985, Volume: 448 Topics: Animals; Ceruletide; Cholecystokinin; Clinical Trials as Topic; Feeding Behavior; Humans; Motor Activity; Parkinson Disease; Receptors, Dopamine; Schizophrenia; Sincalide; Synapses	1985

Other Studies

1 other study(ies) available for sincalide and Parkinson-Disease

Article	Year
CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients. Brain research, 1982, Jul-08, Volume: 243, Issue:1 The regional distribution of immunoassayable CCK-8 was determined in 12 regions of control and parkinsonian human brain, with specific attention to the possible regional coexistence of CCK-8 with dopamine. In Parkinson's disease, CCK-8-I levels were only decreased in the substantia nigra where dopamine cell bodies lie, and not in striatal and corticolimbic dopamine projecting areas. Our results suggest that the major proportion of dopaminergic neurones degenerated in Parkinson's disease may not contain the CCK-8 peptide. Topics: Appetite Depressants; Autopsy; Brain; Brain Chemistry; Cholecystokinin; Humans; Parkinson Disease; Peptide Fragments; Sincalide; Substantia Nigra; Tissue Distribution	1982

Article

Year

CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients.

Brain research, 1982, Jul-08, Volume: 243, Issue:1

The regional distribution of immunoassayable CCK-8 was determined in 12 regions of control and parkinsonian human brain, with specific attention to the possible regional coexistence of CCK-8 with dopamine. In Parkinson's disease, CCK-8-I levels were only decreased in the substantia nigra where dopamine cell bodies lie, and not in striatal and corticolimbic dopamine projecting areas. Our results suggest that the major proportion of dopaminergic neurones degenerated in Parkinson's disease may not contain the CCK-8 peptide.

Topics: Appetite Depressants; Autopsy; Brain; Brain Chemistry; Cholecystokinin; Humans; Parkinson Disease; Peptide Fragments; Sincalide; Substantia Nigra; Tissue Distribution

1982